Nathalie Ferrand

1.6k total citations
51 papers, 1.3k citations indexed

About

Nathalie Ferrand is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nathalie Ferrand has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 17 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Nathalie Ferrand's work include TGF-β signaling in diseases (15 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Pancreatic function and diabetes (6 papers). Nathalie Ferrand is often cited by papers focused on TGF-β signaling in diseases (15 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Pancreatic function and diabetes (6 papers). Nathalie Ferrand collaborates with scholars based in France, United States and Morocco. Nathalie Ferrand's co-authors include Azeddine Atfi, Céline Prunier, Marcia Pessah, François Lallemand, Michèle Sabbah, Su Ryeon Seo, Sébastien L’Hoste, Jacques Camonis, Jacqueline Marais and Jean‐Michel Gauthier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Nathalie Ferrand

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie Ferrand France 22 1.0k 353 180 142 120 51 1.3k
Yan Jin China 23 773 0.8× 262 0.7× 309 1.7× 153 1.1× 219 1.8× 74 1.3k
Emy J. Chen United States 7 857 0.8× 302 0.9× 288 1.6× 76 0.5× 173 1.4× 7 1.4k
Andreas Herrlich United States 20 693 0.7× 267 0.8× 119 0.7× 126 0.9× 141 1.2× 30 1.3k
F. van Valen Germany 22 844 0.8× 491 1.4× 221 1.2× 103 0.7× 272 2.3× 47 1.5k
Éric Tabone France 26 711 0.7× 368 1.0× 193 1.1× 202 1.4× 155 1.3× 57 1.7k
David L. Halladay United States 19 1.2k 1.2× 817 2.3× 127 0.7× 185 1.3× 137 1.1× 25 1.7k
Fumiko Saito-Ohara Japan 16 941 0.9× 437 1.2× 222 1.2× 188 1.3× 73 0.6× 27 1.3k
Fred de Sauvage United States 5 821 0.8× 245 0.7× 270 1.5× 80 0.6× 232 1.9× 8 1.5k
Aleata A. Triplett United States 22 728 0.7× 724 2.1× 207 1.1× 218 1.5× 163 1.4× 34 1.4k
Fangli Ren China 23 931 0.9× 327 0.9× 343 1.9× 111 0.8× 207 1.7× 62 1.4k

Countries citing papers authored by Nathalie Ferrand

Since Specialization
Citations

This map shows the geographic impact of Nathalie Ferrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Ferrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Ferrand more than expected).

Fields of papers citing papers by Nathalie Ferrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Ferrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Ferrand. The network helps show where Nathalie Ferrand may publish in the future.

Co-authorship network of co-authors of Nathalie Ferrand

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Ferrand. A scholar is included among the top collaborators of Nathalie Ferrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Ferrand. Nathalie Ferrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrand, Nathalie, et al.. (2024). A Model for Membrane Degradation Using a Gelatin Invadopodia Assay. Bulletin of Mathematical Biology. 86(3). 30–30.
2.
Ferrand, Nathalie, et al.. (2022). WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells. Cancers. 14(6). 1487–1487. 6 indexed citations
3.
Dilly, Sébastien, Patricia Abbe, Stéphanie Solier, et al.. (2021). Distinction between 2′- and 3′-Phosphate Isomers of a Fluorescent NADPH Analogue Led to Strong Inhibition of Cancer Cells Migration. Antioxidants. 10(5). 723–723. 1 indexed citations
4.
Kobari, Ladan, Martine Auclair, Nathalie Ferrand, et al.. (2021). Circulating cytokines present in multiple myeloma patients inhibit the osteoblastic differentiation of adipose stem cells. Leukemia. 36(2). 540–548. 9 indexed citations
5.
Marchand, Christophe, Marine Vallet, Nathalie Ferrand, et al.. (2020). Secondary Metabolites from the Culture of the Marine-derived Fungus Paradendryphiella salina PC 362H and Evaluation of the Anticancer Activity of Its Metabolite Hyalodendrin. Marine Drugs. 18(4). 191–191. 11 indexed citations
6.
Ferrand, Nathalie, Soraya Fellahi, Jean‐Philippe Bastard, et al.. (2019). Breast-Associated Adipocytes Secretome Induce Fatty Acid Uptake and Invasiveness in Breast Cancer Cells via CD36 Independently of Body Mass Index, Menopausal Status and Mammary Density. Cancers. 11(12). 2012–2012. 53 indexed citations
7.
Béréziat, Véronique, Christelle Mazurier, Martine Auclair, et al.. (2019). Systemic Dysfunction of Osteoblast Differentiation in Adipose-Derived Stem Cells from Patients with Multiple Myeloma. Cells. 8(5). 441–441. 12 indexed citations
8.
Mésange, Paul, Nathalie Ferrand, Michèle Sabbah, et al.. (2018). Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status. Clinical Cancer Research. 24(11). 2548–2558. 14 indexed citations
9.
Ferrand, Nathalie, et al.. (2018). A chemotaxis-based explanation of spheroid formation in 3D cultures of\n breast cancer cells. arXiv (Cornell University). 12 indexed citations
10.
Ferrigno, Olivier, Mingzhu Zhang, Mutsuko Ohnishi, et al.. (2013). Identification of PHRF1 as a Tumor Suppressor that Promotes the TGF-β Cytostatic Program through Selective Release of TGIF-Driven PML Inactivation. Cell Reports. 4(3). 530–541. 28 indexed citations
11.
Ferrand, Nathalie, Azeddine Atfi, & Céline Prunier. (2010). The Oncoprotein c-Ski Functions as a Direct Antagonist of the Transforming Growth Factor-β Type I Receptor. Cancer Research. 70(21). 8457–8466. 23 indexed citations
12.
13.
Faresse, Nourdine, Frédéric Colland, Nathalie Ferrand, et al.. (2008). Identification of PCTA, a TGIF antagonist that promotes PML function in TGF‐β signalling. The EMBO Journal. 27(13). 1804–1815. 31 indexed citations
14.
Atfi, Azeddine, Frédéric Colland, Dominique Bonnier, et al.. (2007). The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor. The Journal of Cell Biology. 178(2). 201–208. 97 indexed citations
15.
Seo, Su Ryeon, Nathalie Ferrand, Nourdine Faresse, et al.. (2006). Nuclear Retention of the Tumor Suppressor cPML by the Homeodomain Protein TGIF Restricts TGF-β Signaling. Molecular Cell. 23(4). 547–559. 63 indexed citations
16.
Prunier, Céline, Marcia Pessah, Nathalie Ferrand, et al.. (2003). The Oncoprotein Ski Acts as an Antagonist of Transforming Growth Factor-β Signaling by Suppressing Smad2 Phosphorylation. Journal of Biological Chemistry. 278(28). 26249–26257. 48 indexed citations
17.
Dennler, Sylviane, Céline Prunier, Nathalie Ferrand, Jean‐Michel Gauthier, & Azeddine Atfi. (2000). c-Jun Inhibits Transforming Growth Factor β-mediated Transcription by Repressing Smad3 Transcriptional Activity. Journal of Biological Chemistry. 275(37). 28858–28865. 77 indexed citations
18.
Emami, Shahin, Nathalie Ferrand, Marcia Pessah, et al.. (1998). Stimulatory Transducing Systems in Pancreatic Islet Cellsa. Annals of the New York Academy of Sciences. 865(1). 118–131. 14 indexed citations
19.
Emami, S., Marcia Pessah, Claudine Boissard, et al.. (1997). Molecular diversity of the adenylyl cyclase-coupled signaling in pancreatic islet cells. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations
20.
Rascle, Anne, Nathalie Ferrand, Olivier Gandrillon, & Jacques Samarut. (1996). Myb-Ets Fusion Oncoprotein Inhibits Thyroid Hormone Receptor/c-ErbA and Retinoic Acid Receptor Functions: a Novel Mechanism of Action for Leukemogenic Transformation by E26 Avian Retrovirus. Molecular and Cellular Biology. 16(11). 6338–6351. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Jin Breakdown of academic impact, for papers by Emy J. Chen Breakdown of academic impact, for papers by Andreas Herrlich Breakdown of academic impact, for papers by F. van Valen Breakdown of academic impact, for papers by Éric Tabone Breakdown of academic impact, for papers by David L. Halladay Breakdown of academic impact, for papers by Fumiko Saito-Ohara Breakdown of academic impact, for papers by Fred de Sauvage Breakdown of academic impact, for papers by Aleata A. Triplett Breakdown of academic impact, for papers by Fangli Ren
Rankless by CCL
2026